This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Before starting a small business, it's crucial to know what you need. This guide outlines the essential tools and resources for success.
22,606 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Robinhood launches its on-chain network, sparking a memecoin surge as traders rush into DeFi and tokenized assets. Th...
A routine call turned into a financial nightmare when a fraudster impersonated Chase Bank, guiding a victim to transf...
A new bullish signal from SK Hynix hints at a lasting memory market upcycle. With Sandisk set to report on Aug. 5, in...
Backpack is launching a year-long staking program that could convert a portion of its tokens into a 20% equity stake ...
Awards season is about glamour, opinions, and yes, money. This guide breaks down the costs behind the red carpet, how...
As Magnachip heads into 2025 earnings season, investors want clarity on revenue growth, margins, and capital allocati...
Public accountability stories grab headlines and shake confidence. This guide explains how such moments can affect yo...
Regulators are tightening what on-chain dollars can be insured, a move that could redefine how stablecoins are used v...
A prominent corporate treasury revealed it may begin selling Bitcoin to raise dollars and reduce debt, ending a long-...
XRP Power unveiled a global AI-powered app that automates yield generation for crypto holders. The platform promises ...
The Long Island Rail Road remains shut down as a sweeping strike stretches into a second day, affecting roughly 250,0...